- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Founded in June 1998, Quest Laboratories Limited produces a diverse range of pharmaceuticals, including antibiotics, antimalarials, anti-inflammatories, etc.
Quest Laboratories' board approved its 28th AGM for Sep 30, 2026, to adopt the financial results for FY26. Key decisions include re-appointing Director Smt. Tejaswini Sabarwal, appointing M/s C.H. Padliya & Co. as Statutory Auditors, and ratifying Cost Auditor fees at Rs. 50,000 p.a.
Quest Laboratories has re-opened its trading window. The company is discontinuing voluntary quarterly financial results, reverting to statutory half-yearly disclosures for SME-listed entities. Consequently, the Q1 results will not be announced, impacting regular investor updates.